Business Context and Reporting Period
This Form 8-K filing by Healthcare Trust, Inc. (Note: The input metadata lists "National Healthcare Properties, Inc.", but the filing text identifies the registrant as "Healthcare Trust, Inc.") reports the determination of the Estimated Per-Share Net Asset Value (NAV) as of December 31, 2019. The report date is March 31, 2020. The Company is a non-listed REIT focused on healthcare real estate assets, including medical office, net lease, and seniors housing properties.
Key Financial Metrics
The filing focuses on asset valuation rather than operational income statements. Key valuation metrics as of December 31, 2019, include:
- Estimated Per-Share NAV: $15.75
- Common Shares Outstanding: 92,762,662
- Real Estate Assets Value: $27.91 per share (Total portfolio value approx. $2.59 billion)
- Other Assets: $1.49 per share
- Fair Value of Debt: $(12.57) per share
- Other Liabilities: $(0.65) per share
- Series A Preferred Stock Liquidation Value: $(0.43) per share
- Valuation Range (Sensitivity Analysis): $14.33 (Low) to $16.33 (High), with a midpoint of $15.30.
Material Changes Versus Prior Period
Comparing the December 31, 2019 valuation to December 31, 2018:
- Estimated Per-Share NAV: Decreased from $17.50 to $15.75.
- Real Estate Assets: Decreased from $28.12 per share to $27.91 per share.
- Debt: Increased from $(11.65) per share to $(12.57) per share.
- Preferred Stock: A new deduction of $(0.43) per share was introduced due to the issuance of 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock in December 2019.
- Asset Performance: The estimated value of Real Estate Assets reflects a 3.5% decrease below the sum of original investment costs ($2.7 billion) and subsequent capital expenditures ($53.0 million).
Guidance, Outlook, Risks, and Unusual Items
Management Commentary and Outlook: The Advisor stated it is too early to determine the nature and scope of the impact of the ongoing coronavirus pandemic on the Company or the NAV as of December 31, 2019. Consequently, no material changes were identified between the valuation date and the filing date.
Risks and Contingencies:
- Pandemic Risk: The filing explicitly references the risk of the global coronavirus pandemic adversely affecting the Company, its tenants, and the global economy.
- Valuation Limitations: The Estimated Per-Share NAV does not reflect a liquidity discount, costs of sale, or enterprise value premiums. It is not a guarantee of the price at which shares would trade or the amount received in a liquidation.
- Methodology Sensitivity: Valuation is highly sensitive to capitalization rates (weighted average 6.47%) and discount rates (weighted average 8.30%).
Unusual Items: The filing notes that in a hypothetical liquidation at the determined NAV, the Advisor would not be entitled to any incentive fees or Class B Units.
Important Facts for Investor Verification
- Verify the discrepancy between the metadata company name ("National Healthcare Properties, Inc.") and the filing registrant ("Healthcare Trust, Inc.").
- Confirm the 10.0% decline in Estimated Per-Share NAV from the prior year ($17.50 to $15.75) and the specific drivers (debt increase, preferred stock issuance, asset value decline).
- Review the sensitivity analysis showing the NAV could range from $14.33 to $16.33 based on market rate assumptions.
- Understand that the NAV does not account for the liquidity discount inherent in non-listed REITs.
- Note that the valuation was performed on a "desktop basis" by Duff & Phelps, LLC, relying on Company-provided data.